Clinical Trial Update: Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus Adefovir [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating tenofovir disoproxil fumarate monotherapy in chronic hepatitis B patients who achieved suppression on lamivudine plus adefov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Uijeongbu St. Mary Hospital | Conditions: Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48 | Phase 3 | Status: UNKNOWN